日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The role of the tumor microenvironment in drug resistance acquisition in lung squamous cell carcinoma

肿瘤微环境在肺鳞状细胞癌耐药性获得中的作用

Zanoaga, Oana; Braicu, Cornelia; Nutu, Andreea; Berindan-Neagoe, Ioana; Bender, Andreas

Fats and Facts: A Meta-Analysis of Lipid Biomarkers in Endometrial Cancer

脂肪与真相:子宫内膜癌脂质生物标志物的荟萃分析

Clim, Ioana Adelina; Faur, Ionut Flaviu; Prodan-Barbulescu, Catalin; Neamtu, Andreea-Adriana; Pasca, Paul; Burta, Cosmin; Bara, Sergiu Florin; Brebu, Dan; Braicu, Vlad; Duta, Ciprian; Totolici, Bogdan; Neamtu, Carmen; Dobrescu, Amadeus

A Meta-Analysis on the Long-Term Impact of Cytoreductive Surgery Plus HIPEC for Ovarian Cancer with Peritoneal Metastasis: Are We on the Right Path?

细胞减灭术联合 HIPEC 治疗腹膜转移性卵巢癌的长期疗效荟萃分析:我们走在正确的道路上吗?

Brebu, Dan; Șelaru, Mircea; Faur, Ionut Flaviu; Burta, Mihai Cosmin; Faur, Ioana Adelina; Dobrescu, Amadeus; Duță, Ciprian; Braicu, Vlad; Neamțu, Andreea-Adriana; Răzvan, Danau

Between research and introduction to clinical routine-Experience with niraparib from the compassionate use program in Germany (NOGGO Register Analysis)

从研究到临床常规应用——德国同情用药项目中尼拉帕尼的经验(NOGGO 注册分析)

Grabowski, Jacek P; Welz, Julia; Heublein, Sabine; Krajewska, Maja; Boer, Jolijn D; Kraus, Fabian; Arndt, Tjadina; Moosmann, Nicolas; Heinrich, Bernhard; Engler, Tobias; Agabejli, Saida; Ugur, Mustafa Celalettin; Witteler, Ralf; Albrecht, Oliver; Müller-Huesmann, Harald; Oskay-Özcelik, Gülten; Hettwer, Cristina; Kaiser, Sabrina; Braicu, Elena; Sehouli, Jalid

Characterization of exceptional responders with long-term PARP inhibitor therapy in recurrent ovarian cancer: an analysis of 23 patients from Charité

对接受长期 PARP 抑制剂治疗的复发性卵巢癌患者进行特征分析:来自柏林夏里特医院的 23 例患者的研究

Glajzer, Jacek; Sehouli, Jalid; Woopen, Hannah; Braicu, Elena Ioana; Baum, Joanna; Grabowski, Jacek P

Molecular Signatures and Network Alterations Underlying GBM Progression and Recurrence

胶质母细胞瘤进展和复发的分子特征和网络改变

Pop Crisan, Andrea; Ciocan, Cristina; Pirlog, Radu; Necula, Alexandru; Al Hajjar, Darius Adin; Pruteanu, Lavinia-Lorena; Busuioc, Constantin-Ioan; Pandey, Deo Prakash; Mohan, Aurel George; Braicu, Cornelia; Berindan-Neagoe, Ioana

Transforming treatment paradigms: Focus on personalized medicine for high-grade serous ovarian cancer

转变治疗模式:聚焦高级别浆液性卵巢癌的个体化治疗

Kordowitzki, Pawel; Lange, Britta; Elias, Kevin M; Haigis, Marcia C; Mechsner, Sylvia; Braicu, Ioana Elena; Sehouli, Jalid

First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial

一线乐伐替尼联合帕博利珠单抗对比化疗治疗晚期子宫内膜癌:一项随机、开放标签的III期试验

Marth, Christian; Moore, Richard G; Bidziński, Mariusz; Pignata, Sandro; Ayhan, Ali; Rubio, M Jesús; Beiner, Mario; Hall, Marcia; Vulsteke, Christof; Braicu, Elena Ioana; Sonoda, Kenzo; Wu, Xiaohua; Frentzas, Sophia; Mattar, André; Lheureux, Stephanie; Chen, Xiaojun; Hasegawa, Kosei; Magallanes-Maciel, Manuel; Choi, Chel Hun; Shalkova, Mariia; Kaen, Diego; Wang, Peng-Hui; Berger, Regina; Okpara, Chinyere E; McKenzie, Jodi; Yao, Lili; Orlowski, Robert; Khemka, Vivek; Gilbert, Lucy; Makker, Vicky

Correction: ERRα promotes glycolytic metabolism and targets the NLRP3/caspase-1/GSDMD pathway to regulate pyroptosis in endometrial cancer

更正:ERRα促进糖酵解代谢,并靶向NLRP3/caspase-1/GSDMD通路以调节子宫内膜癌中的细胞焦亡。

Su, Pingping; Mao, Xiaodan; Ma, Jincheng; Huang, Lixiang; Yu, Lirui; Tang, Shuting; Zhuang, Mingzhi; Lu, Zhonglei; Osafo, Kelvin Stefan; Ren, Yuan; Wang, Xinrui; Lin, Xite; Huang, Leyi; Huang, Xiaoli; Braicu, Elena Ioana; Sehouli, Jalid; Sun, Pengming

Circadian rhythm disruption by PARP inhibitors correlates with treatment toxicity in patients with ovarian cancer and is a predictor of side effects

PARP抑制剂引起的昼夜节律紊乱与卵巢癌患者的治疗毒性相关,并且是副作用的预测指标。

Malhan, Deeksha; Hesse, Janina; Nelson, Nina; Stankov, Kay; Nguyen, Jessica; Aboumanify, Ouda; Garmshausen, Josefin; Rogmans, Gunther; Czogalla, Bastian; Gerber, Jens; Koch, Martin; Kupec, Tomáš; Tomé, Oliver; Witteler, Ralf; Deryal, Mustafa; Eichbaum, Michael; Sehouli, Jalid; Braicu, Elena Ioana; Relógio, Angela